Quotient Diagnostics Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 19

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $8.05M

Quotient Diagnostics General Information

Description

Developer of immunohematology products. The company develops testing technologies for the diagnosis and treatment of diabetes and associated diseases. It also provides point-of-care devices for glycated hemoglobin measurement.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Russell House
  • Molesey Road, Walton-on-Thames
  • Surrey KT12 3PE
  • England, United Kingdom
+44 01932
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • Russell House
  • Molesey Road, Walton-on-Thames
  • Surrey KT12 3PE
  • England, United Kingdom
+44 01932

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quotient Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 04-Oct-2010 $8.05M Completed Generating Revenue
6. Debt - General 01-Feb-2010 Completed Generating Revenue
5. Later Stage VC 16-Jul-2009 Completed Generating Revenue
4. Later Stage VC 01-Apr-2008 Completed Generating Revenue
3. Early Stage VC 21-Jul-2006 Completed Product Development
2. Early Stage VC 16-Aug-2005 $1.2M Completed Product Development
1. Early Stage VC 18-Jul-2005 $1.2M $1.2M Completed Product Development
To view Quotient Diagnostics’s complete valuation and funding history, request access »

Quotient Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Quotient Diagnostics’s complete cap table history, request access »

Quotient Diagnostics Patents

Quotient Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0705495-D0 Whole blood assay Inactive 22-Mar-2007
WO-2008114060-A1 Whole blood assay Inactive 22-Mar-2007
ES-2377232-T3 Fluorescent analysis Active 31-Mar-2006
EP-2005164-A2 Fluorescent assay Active 31-Mar-2006
EP-2005164-B1 Fluorescent assay Active 31-Mar-2006 G01N33/721
To view Quotient Diagnostics’s complete patent history, request access »

Quotient Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quotient Diagnostics Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
BBI Holdings Corporation Minority
GEIF Ventures Venture Capital Minority
IQ Capital Partners Venture Capital Minority
Italian Angels for Growth Angel Group Minority
London Business Angels Angel Group Minority
You’re viewing 5 of 10 investors. Get the full list »

Quotient Diagnostics FAQs

  • When was Quotient Diagnostics founded?

    Quotient Diagnostics was founded in 2003.

  • Where is Quotient Diagnostics headquartered?

    Quotient Diagnostics is headquartered in Surrey, United Kingdom.

  • What is the size of Quotient Diagnostics?

    Quotient Diagnostics has 19 total employees.

  • What industry is Quotient Diagnostics in?

    Quotient Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Quotient Diagnostics a private or public company?

    Quotient Diagnostics is a Private company.

  • What is the current valuation of Quotient Diagnostics?

    The current valuation of Quotient Diagnostics is .

  • What is Quotient Diagnostics’s current revenue?

    The current revenue for Quotient Diagnostics is .

  • How much funding has Quotient Diagnostics raised over time?

    Quotient Diagnostics has raised $4.56M.

  • Who are Quotient Diagnostics’s investors?

    BBI Holdings, GEIF Ventures, IQ Capital Partners, Italian Angels for Growth, and London Business Angels are 5 of 10 investors who have invested in Quotient Diagnostics.

  • When was Quotient Diagnostics acquired?

    Quotient Diagnostics was acquired on 04-Oct-2010.

  • Who acquired Quotient Diagnostics?

    Quotient Diagnostics was acquired by EKF Diagnostics Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process